NASDAQ: ACHC - Acadia Healthcare Company, Inc.

Yield per half year: -61.92%
Dividend yield: 0.00%
Sector: Healthcare

Company Analysis Acadia Healthcare Company, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Current debt level 26.11% is below 100% and has decreased over 5 years from 53.49%.

Disadvantages

  • Price (28.81 $) is higher than fair price (1.98 $)
  • Dividends (0%) are below the sector average (0.5467%).
  • The stock's return over the last year (-63.22%) is lower than the sector average (-25.51%).
  • The company's current efficiency (ROE=-0.7788%) is lower than the sector average (ROE=9.01%)

Similar companies

Illumina

Incyte

ImmunoGen

DENTSPLY SIRONA

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Acadia Healthcare Company, Inc. Healthcare Index
7 days -1.5% -20.9% -6.5%
90 days -23.5% -25.3% -12.6%
1 year -63.2% -25.5% 3.4%

ACHC vs Sector: Acadia Healthcare Company, Inc. has significantly underperformed the "Healthcare" sector by -37.72% over the past year.

ACHC vs Market: Acadia Healthcare Company, Inc. has significantly underperformed the market by -66.63% over the past year.

Stable price: ACHC is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: ACHC with weekly volatility of -1.22% over the past year.

3. Summary of the report

3.1. General

P/E: 27.82
P/S: 2.42

3.2. Revenue

EPS -0.2382
ROE -0.7788%
ROA -0.4043%
ROIC 7.13%
Ebitda margin 21.82%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (28.81 $) is higher than the fair price (1.98 $).

Price is higher than fair: The current price (28.81 $) is 93.1% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (27.82) is lower than that of the sector as a whole (57.09).

P/E vs Market: The company's P/E (27.82) is lower than that of the market as a whole (48.45).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (2.45) is lower than that of the sector as a whole (4.61).

P/BV vs Market: The company's P/BV (2.45) is lower than that of the market as a whole (3.38).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (2.42) is lower than that of the sector as a whole (33.5).

P/S vs Market: The company's P/S indicator (2.42) is lower than that of the market as a whole (10.23).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (13.29) is higher than that of the sector as a whole (-19.46).

EV/Ebitda vs Market: The company's EV/Ebitda (13.29) is lower than that of the market as a whole (15.44).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -23.03% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-23.03%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (38.84%).

5.4. ROE

ROE vs Sector: The company's ROE (-0.7788%) is lower than that of the sector as a whole (9.01%).

ROE vs Market: The company's ROE (-0.7788%) is lower than that of the market as a whole (8.97%).

5.5. ROA

ROA vs Sector: The company's ROA (-0.4043%) is lower than that of the sector as a whole (0.0151%).

ROA vs Market: The company's ROA (-0.4043%) is lower than that of the market as a whole (6.3%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (7.13%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (7.13%) is lower than that of the market as a whole (10.96%).

6. Finance

6.1. Assets and debt

Debt level: (26.11%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 53.49% to 26.11%.

Excess of debt: The debt is not covered by net income, percentage -6456.94%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.5467%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0.2001%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Acadia Healthcare Company, Inc.

9.3. Comments